Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Ultrasonography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 7 Thyroid Nodule 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcopenia 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Neoplasms 3 Mouth Neoplasms 3 Liver Neoplasms 3 Liver Cirrhosis 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Thyroid Neoplasms 2 Ovarian Neoplasms 2 Ovarian Cysts 2 Lung Neoplasms 2 Hypersensitivity 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Thrombosis 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1

Interventions

Ipilimumab 14 Nivolumab 12 incomplete Freund's adjuvant 8 Cyclophosphamide 7 pembrolizumab 6 Ranibizumab 6 CTLA-4 Antigen 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Biopsy 4 tebentafusp 3 aflibercept 3 Temozolomide 3 Sunitinib 3 Specimen Handling 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 montanide ISA 51 2 lenvatinib 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Triamcinolone Acetonide 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06284512 2024-02-29

Uveal Melanoma - Comparative Study

Medical University of Vienna

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡